| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environmental Pollution | 29 | 2024 | 125 | 10.460 |
Why?
|
| Environmental Health | 52 | 2025 | 298 | 8.840 |
Why?
|
| Child Welfare | 44 | 2022 | 523 | 6.990 |
Why?
|
| Environmental Exposure | 144 | 2025 | 4543 | 6.510 |
Why?
|
| Asbestos | 28 | 2021 | 251 | 5.400 |
Why?
|
| Occupational Diseases | 92 | 2018 | 1457 | 5.150 |
Why?
|
| Occupational Exposure | 46 | 2022 | 1807 | 4.410 |
Why?
|
| September 11 Terrorist Attacks | 22 | 2018 | 107 | 4.140 |
Why?
|
| Air Pollution | 25 | 2024 | 2374 | 3.990 |
Why?
|
| Plastics | 8 | 2024 | 119 | 3.690 |
Why?
|
| Lead Poisoning | 46 | 2024 | 323 | 3.660 |
Why?
|
| Lead | 54 | 2024 | 882 | 3.320 |
Why?
|
| Environmental Pollutants | 40 | 2024 | 1296 | 3.280 |
Why?
|
| Occupational Medicine | 14 | 2018 | 116 | 3.090 |
Why?
|
| Pesticides | 17 | 2024 | 298 | 2.410 |
Why?
|
| Climate Change | 12 | 2024 | 509 | 2.270 |
Why?
|
| Fossil Fuels | 4 | 2024 | 53 | 2.010 |
Why?
|
| Occupational Health | 11 | 2020 | 812 | 2.000 |
Why?
|
| Herbicides | 7 | 2024 | 104 | 1.780 |
Why?
|
| Air Pollutants | 21 | 2024 | 2916 | 1.660 |
Why?
|
| International Cooperation | 13 | 2023 | 1436 | 1.630 |
Why?
|
| Methylmercury Compounds | 9 | 2024 | 103 | 1.540 |
Why?
|
| Developing Countries | 19 | 2025 | 2910 | 1.510 |
Why?
|
| Mercury | 10 | 2022 | 289 | 1.430 |
Why?
|
| Neurotoxicity Syndromes | 6 | 2018 | 302 | 1.420 |
Why?
|
| Public Policy | 13 | 2021 | 552 | 1.400 |
Why?
|
| Public Health | 23 | 2024 | 2679 | 1.390 |
Why?
|
| Hazardous Substances | 8 | 2014 | 153 | 1.370 |
Why?
|
| Government Regulation | 8 | 2021 | 525 | 1.320 |
Why?
|
| Carcinogens | 10 | 2017 | 453 | 1.270 |
Why?
|
| Asbestosis | 10 | 2017 | 81 | 1.250 |
Why?
|
| Mesothelioma | 8 | 2021 | 811 | 1.240 |
Why?
|
| Ecosystem | 4 | 2023 | 494 | 1.240 |
Why?
|
| Rescue Work | 6 | 2012 | 58 | 1.230 |
Why?
|
| United States Environmental Protection Agency | 14 | 2019 | 139 | 1.170 |
Why?
|
| Developmental Disabilities | 9 | 2018 | 1518 | 1.140 |
Why?
|
| Soil Pollutants | 7 | 2024 | 78 | 1.100 |
Why?
|
| Food Contamination | 8 | 2024 | 193 | 1.050 |
Why?
|
| Conservation of Natural Resources | 6 | 2024 | 209 | 1.020 |
Why?
|
| Humans | 449 | 2025 | 768166 | 1.020 |
Why?
|
| Arsenic | 11 | 2017 | 358 | 1.020 |
Why?
|
| Endocrine Disruptors | 2 | 2023 | 265 | 0.970 |
Why?
|
| Pediatrics | 13 | 2025 | 3629 | 0.960 |
Why?
|
| Child | 135 | 2025 | 80917 | 0.940 |
Why?
|
| Metals | 6 | 2022 | 713 | 0.920 |
Why?
|
| Catholicism | 1 | 2024 | 32 | 0.910 |
Why?
|
| Asthma | 19 | 2023 | 6291 | 0.910 |
Why?
|
| Particulate Matter | 8 | 2024 | 2617 | 0.900 |
Why?
|
| Glycine | 5 | 2018 | 672 | 0.900 |
Why?
|
| Social Justice | 4 | 2024 | 486 | 0.900 |
Why?
|
| Health Policy | 12 | 2018 | 2698 | 0.880 |
Why?
|
| Occupational Health Services | 7 | 2015 | 149 | 0.880 |
Why?
|
| Cardiovascular Diseases | 15 | 2024 | 15662 | 0.880 |
Why?
|
| Hazardous Waste | 6 | 2015 | 23 | 0.850 |
Why?
|
| Industry | 9 | 2016 | 362 | 0.850 |
Why?
|
| Flame Retardants | 2 | 2024 | 97 | 0.840 |
Why?
|
| Communicable Diseases | 3 | 2024 | 874 | 0.830 |
Why?
|
| Dust | 14 | 2018 | 488 | 0.800 |
Why?
|
| Phenols | 6 | 2024 | 526 | 0.780 |
Why?
|
| Intelligence | 6 | 2024 | 926 | 0.770 |
Why?
|
| New York City | 23 | 2018 | 737 | 0.760 |
Why?
|
| Environmental Monitoring | 18 | 2016 | 1469 | 0.760 |
Why?
|
| Aspartame | 1 | 2021 | 19 | 0.750 |
Why?
|
| United States | 115 | 2024 | 73039 | 0.750 |
Why?
|
| Air Pollutants, Occupational | 14 | 2011 | 406 | 0.750 |
Why?
|
| Academies and Institutes | 2 | 2019 | 326 | 0.750 |
Why?
|
| Food, Genetically Modified | 2 | 2024 | 6 | 0.740 |
Why?
|
| Mercury Poisoning | 4 | 2013 | 32 | 0.730 |
Why?
|
| History, 21st Century | 10 | 2019 | 1573 | 0.720 |
Why?
|
| History, 20th Century | 15 | 2019 | 2766 | 0.710 |
Why?
|
| Minority Health | 1 | 2021 | 79 | 0.700 |
Why?
|
| Legislation as Topic | 2 | 2019 | 76 | 0.700 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1885 | 0.680 |
Why?
|
| Mining | 9 | 2024 | 93 | 0.680 |
Why?
|
| New York | 17 | 2018 | 882 | 0.670 |
Why?
|
| United States Occupational Safety and Health Administration | 5 | 2016 | 54 | 0.650 |
Why?
|
| Economic Development | 2 | 2019 | 72 | 0.630 |
Why?
|
| Seafood | 4 | 2024 | 395 | 0.620 |
Why?
|
| Sweetening Agents | 1 | 2021 | 290 | 0.620 |
Why?
|
| Relief Work | 2 | 2011 | 131 | 0.610 |
Why?
|
| Leadership | 2 | 2024 | 1397 | 0.610 |
Why?
|
| Climate | 2 | 2018 | 146 | 0.590 |
Why?
|
| Carcinogens, Environmental | 4 | 2011 | 70 | 0.590 |
Why?
|
| Epidemiology | 5 | 2015 | 278 | 0.590 |
Why?
|
| Social Responsibility | 2 | 2020 | 382 | 0.570 |
Why?
|
| Asbestos, Serpentine | 5 | 2021 | 24 | 0.570 |
Why?
|
| Accidents, Occupational | 9 | 2000 | 251 | 0.570 |
Why?
|
| Construction Materials | 5 | 2019 | 60 | 0.560 |
Why?
|
| Environmental Policy | 3 | 2013 | 36 | 0.560 |
Why?
|
| Oceans and Seas | 3 | 2024 | 47 | 0.560 |
Why?
|
| Plants, Genetically Modified | 2 | 2024 | 113 | 0.560 |
Why?
|
| Global Warming | 2 | 2024 | 79 | 0.550 |
Why?
|
| Neoplasms | 35 | 2021 | 22371 | 0.540 |
Why?
|
| Planets | 1 | 2016 | 7 | 0.540 |
Why?
|
| Morbidity | 6 | 2016 | 1755 | 0.540 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 2 | 2010 | 18 | 0.530 |
Why?
|
| Terrorism | 3 | 2004 | 211 | 0.520 |
Why?
|
| Healthy People Programs | 1 | 2016 | 54 | 0.520 |
Why?
|
| Water Pollution | 4 | 2024 | 31 | 0.520 |
Why?
|
| Herbicide Resistance | 1 | 2015 | 2 | 0.520 |
Why?
|
| Cost of Illness | 9 | 2024 | 1951 | 0.510 |
Why?
|
| Metals, Heavy | 2 | 2007 | 149 | 0.510 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 1 | 2015 | 25 | 0.510 |
Why?
|
| Child, Preschool | 72 | 2024 | 42669 | 0.500 |
Why?
|
| Benzene | 8 | 1996 | 106 | 0.500 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2015 | 7 | 0.500 |
Why?
|
| Hydrocarbons, Chlorinated | 3 | 2008 | 120 | 0.500 |
Why?
|
| World Health Organization | 8 | 2017 | 1329 | 0.500 |
Why?
|
| Consensus | 3 | 2020 | 3212 | 0.490 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2023 | 2538 | 0.490 |
Why?
|
| Risk Assessment | 29 | 2024 | 24315 | 0.480 |
Why?
|
| Population Surveillance | 6 | 2017 | 2596 | 0.480 |
Why?
|
| Infertility | 2 | 2018 | 655 | 0.480 |
Why?
|
| Recycling | 4 | 2024 | 16 | 0.470 |
Why?
|
| Electronic Waste | 3 | 2020 | 4 | 0.460 |
Why?
|
| Nervous System | 4 | 2014 | 544 | 0.460 |
Why?
|
| Industrial Waste | 7 | 1999 | 24 | 0.460 |
Why?
|
| Preventive Medicine | 4 | 2006 | 246 | 0.450 |
Why?
|
| Household Products | 1 | 2013 | 26 | 0.440 |
Why?
|
| Heart Diseases | 2 | 2024 | 2819 | 0.440 |
Why?
|
| Solvents | 5 | 2006 | 298 | 0.440 |
Why?
|
| Health Services Needs and Demand | 4 | 2018 | 1406 | 0.430 |
Why?
|
| Monaco | 2 | 2023 | 2 | 0.430 |
Why?
|
| Health Facilities | 1 | 2018 | 578 | 0.430 |
Why?
|
| Aristolochic Acids | 1 | 2012 | 13 | 0.420 |
Why?
|
| Lung Neoplasms | 15 | 2023 | 13586 | 0.420 |
Why?
|
| Military Personnel | 3 | 2021 | 1261 | 0.420 |
Why?
|
| Body Burden | 8 | 2020 | 158 | 0.410 |
Why?
|
| Herbal Medicine | 1 | 2012 | 37 | 0.410 |
Why?
|
| Epidemiologic Methods | 24 | 1998 | 1328 | 0.410 |
Why?
|
| Food Labeling | 1 | 2015 | 181 | 0.410 |
Why?
|
| Policy Making | 6 | 2010 | 546 | 0.410 |
Why?
|
| Texas | 8 | 2023 | 410 | 0.410 |
Why?
|
| Metallurgy | 9 | 1998 | 90 | 0.390 |
Why?
|
| Employment | 6 | 1997 | 1110 | 0.390 |
Why?
|
| Aircraft | 2 | 2004 | 135 | 0.390 |
Why?
|
| Ships | 5 | 2021 | 53 | 0.390 |
Why?
|
| Water Pollutants, Chemical | 6 | 2024 | 359 | 0.380 |
Why?
|
| Autistic Disorder | 2 | 2012 | 1240 | 0.380 |
Why?
|
| Societies, Scientific | 3 | 2018 | 223 | 0.370 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 146 | 0.370 |
Why?
|
| Costs and Cost Analysis | 7 | 2018 | 1667 | 0.360 |
Why?
|
| Disaster Planning | 3 | 2017 | 560 | 0.360 |
Why?
|
| Nervous System Diseases | 16 | 1998 | 1662 | 0.360 |
Why?
|
| Epidemiologic Studies | 5 | 2006 | 677 | 0.350 |
Why?
|
| Water Supply | 10 | 2017 | 204 | 0.350 |
Why?
|
| Dental Materials | 1 | 2010 | 113 | 0.340 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 3415 | 0.340 |
Why?
|
| Respiratory Tract Diseases | 6 | 2011 | 744 | 0.330 |
Why?
|
| Xenobiotics | 2 | 2000 | 71 | 0.330 |
Why?
|
| History, 19th Century | 7 | 2017 | 714 | 0.330 |
Why?
|
| Power Plants | 4 | 2023 | 125 | 0.320 |
Why?
|
| Cohort Studies | 18 | 2018 | 41754 | 0.320 |
Why?
|
| Persian Gulf Syndrome | 3 | 1998 | 48 | 0.320 |
Why?
|
| Pregnancy | 32 | 2024 | 30256 | 0.320 |
Why?
|
| Infant | 48 | 2023 | 36535 | 0.320 |
Why?
|
| Schools, Medical | 3 | 2011 | 883 | 0.320 |
Why?
|
| Chemical Industry | 10 | 1996 | 115 | 0.310 |
Why?
|
| Pandemics | 3 | 2022 | 8748 | 0.310 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.310 |
Why?
|
| Maternal Exposure | 4 | 2020 | 1096 | 0.310 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3238 | 0.310 |
Why?
|
| Female | 115 | 2024 | 397192 | 0.310 |
Why?
|
| Polychlorinated Biphenyls | 5 | 2015 | 235 | 0.300 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2008 | 25 | 0.300 |
Why?
|
| Stress Disorders, Post-Traumatic | 10 | 2018 | 4640 | 0.300 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3252 | 0.300 |
Why?
|
| Water Pollutants, Radioactive | 1 | 2007 | 2 | 0.300 |
Why?
|
| Butadienes | 3 | 1993 | 107 | 0.290 |
Why?
|
| Primary Prevention | 5 | 2013 | 1188 | 0.290 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2008 | 454 | 0.290 |
Why?
|
| Uranium | 1 | 2007 | 24 | 0.290 |
Why?
|
| Adult | 95 | 2022 | 223646 | 0.290 |
Why?
|
| Toxicology | 5 | 2015 | 103 | 0.290 |
Why?
|
| Health Status | 5 | 2016 | 4091 | 0.290 |
Why?
|
| Memory Disorders | 1 | 2014 | 1200 | 0.280 |
Why?
|
| Politics | 3 | 2023 | 822 | 0.280 |
Why?
|
| Leukemia | 9 | 1998 | 1519 | 0.280 |
Why?
|
| Maximum Allowable Concentration | 13 | 2004 | 64 | 0.280 |
Why?
|
| Poverty | 8 | 2020 | 2720 | 0.280 |
Why?
|
| Vehicle Emissions | 2 | 2002 | 651 | 0.280 |
Why?
|
| United States Food and Drug Administration | 2 | 2009 | 1673 | 0.270 |
Why?
|
| Birth Weight | 4 | 2023 | 2121 | 0.270 |
Why?
|
| Kidney Diseases | 6 | 2007 | 2100 | 0.270 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 2420 | 0.270 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2024 | 84 | 0.270 |
Why?
|
| Soil | 4 | 2024 | 120 | 0.260 |
Why?
|
| Water Pollutants | 3 | 2017 | 25 | 0.260 |
Why?
|
| Human Experimentation | 2 | 2004 | 125 | 0.260 |
Why?
|
| Hospitals, Teaching | 1 | 2011 | 1157 | 0.260 |
Why?
|
| Biomedical Research | 2 | 2015 | 3463 | 0.260 |
Why?
|
| Germany | 2 | 2018 | 883 | 0.260 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 724 | 0.260 |
Why?
|
| Male | 114 | 2024 | 364719 | 0.260 |
Why?
|
| International Agencies | 2 | 2016 | 244 | 0.260 |
Why?
|
| Capacity Building | 2 | 2019 | 265 | 0.260 |
Why?
|
| Registries | 9 | 2013 | 8375 | 0.260 |
Why?
|
| Fires | 4 | 2001 | 170 | 0.260 |
Why?
|
| Pregnancy Outcome | 4 | 2023 | 2972 | 0.260 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2012 | 794 | 0.250 |
Why?
|
| Fishes | 2 | 2005 | 606 | 0.250 |
Why?
|
| Chronic Disease | 8 | 2017 | 9384 | 0.250 |
Why?
|
| Crisis Intervention | 1 | 2006 | 111 | 0.250 |
Why?
|
| Interprofessional Relations | 4 | 2015 | 997 | 0.240 |
Why?
|
| Faculty, Medical | 3 | 2017 | 1226 | 0.240 |
Why?
|
| Consensus Development Conferences as Topic | 3 | 2016 | 169 | 0.240 |
Why?
|
| Disease | 2 | 2008 | 675 | 0.240 |
Why?
|
| Refuse Disposal | 4 | 2012 | 31 | 0.240 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 4916 | 0.240 |
Why?
|
| Vulnerable Populations | 2 | 2015 | 718 | 0.230 |
Why?
|
| Research | 8 | 2018 | 1979 | 0.230 |
Why?
|
| Financing, Government | 3 | 2019 | 473 | 0.230 |
Why?
|
| Infant, Newborn | 15 | 2023 | 26422 | 0.230 |
Why?
|
| Housing | 7 | 2008 | 683 | 0.230 |
Why?
|
| Biodiversity | 2 | 2024 | 345 | 0.230 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 1465 | 0.230 |
Why?
|
| Fetal Development | 3 | 2021 | 779 | 0.230 |
Why?
|
| Research Design | 12 | 2018 | 6211 | 0.230 |
Why?
|
| Writing | 1 | 2006 | 200 | 0.220 |
Why?
|
| Insecticides | 4 | 2002 | 200 | 0.220 |
Why?
|
| Coal | 2 | 2023 | 122 | 0.220 |
Why?
|
| Fresh Water | 2 | 2017 | 83 | 0.220 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 857 | 0.220 |
Why?
|
| Benzhydryl Compounds | 3 | 2024 | 944 | 0.220 |
Why?
|
| Italy | 3 | 2018 | 856 | 0.220 |
Why?
|
| Intelligence Tests | 1 | 2024 | 504 | 0.220 |
Why?
|
| Ethics, Professional | 1 | 2003 | 100 | 0.210 |
Why?
|
| Federal Government | 2 | 2004 | 266 | 0.210 |
Why?
|
| Carbon | 2 | 2024 | 673 | 0.210 |
Why?
|
| Conflict of Interest | 3 | 2003 | 556 | 0.210 |
Why?
|
| Publishing | 4 | 2003 | 837 | 0.210 |
Why?
|
| Internationality | 2 | 2005 | 1008 | 0.210 |
Why?
|
| Disease Outbreaks | 11 | 2018 | 1761 | 0.210 |
Why?
|
| Mortality | 7 | 2013 | 2911 | 0.210 |
Why?
|
| Animals | 35 | 2023 | 169246 | 0.210 |
Why?
|
| Endocrine System | 1 | 2003 | 113 | 0.210 |
Why?
|
| Air Pollution, Indoor | 4 | 2008 | 931 | 0.210 |
Why?
|
| Petroleum | 1 | 2002 | 82 | 0.200 |
Why?
|
| Europe, Eastern | 1 | 2022 | 72 | 0.200 |
Why?
|
| Pesticide Residues | 3 | 2018 | 95 | 0.200 |
Why?
|
| Bereavement | 1 | 2007 | 310 | 0.200 |
Why?
|
| Administrative Personnel | 1 | 2024 | 185 | 0.200 |
Why?
|
| Congenital Abnormalities | 4 | 2018 | 703 | 0.200 |
Why?
|
| Lung Diseases | 3 | 2011 | 1944 | 0.200 |
Why?
|
| State Government | 3 | 2018 | 388 | 0.200 |
Why?
|
| Stroke | 2 | 2024 | 9755 | 0.200 |
Why?
|
| Protoporphyrins | 8 | 1998 | 168 | 0.200 |
Why?
|
| Homicide | 1 | 2005 | 294 | 0.200 |
Why?
|
| Toxicity Tests | 5 | 2017 | 114 | 0.200 |
Why?
|
| Altruism | 1 | 2024 | 211 | 0.190 |
Why?
|
| Polycyclic Compounds | 3 | 1990 | 28 | 0.190 |
Why?
|
| New Jersey | 6 | 2018 | 296 | 0.190 |
Why?
|
| Career Choice | 2 | 2019 | 769 | 0.190 |
Why?
|
| Bone and Bones | 5 | 1994 | 2589 | 0.190 |
Why?
|
| Program Development | 1 | 2008 | 1300 | 0.190 |
Why?
|
| Child Behavior Disorders | 2 | 2018 | 812 | 0.190 |
Why?
|
| Chelating Agents | 3 | 2000 | 385 | 0.190 |
Why?
|
| Rwanda | 1 | 2024 | 671 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2006 | 4055 | 0.190 |
Why?
|
| Dioxins | 2 | 2020 | 91 | 0.180 |
Why?
|
| Models, Theoretical | 2 | 2004 | 3573 | 0.180 |
Why?
|
| Social Planning | 1 | 2020 | 9 | 0.180 |
Why?
|
| Styrenes | 3 | 1993 | 23 | 0.180 |
Why?
|
| Infertility, Male | 2 | 2000 | 397 | 0.180 |
Why?
|
| Milk, Human | 3 | 2020 | 490 | 0.180 |
Why?
|
| Truth Disclosure | 2 | 1995 | 434 | 0.180 |
Why?
|
| Minerals | 1 | 2022 | 282 | 0.180 |
Why?
|
| Incidence | 16 | 2013 | 21538 | 0.180 |
Why?
|
| Inhalation Exposure | 3 | 2012 | 432 | 0.180 |
Why?
|
| Succimer | 1 | 2000 | 31 | 0.180 |
Why?
|
| Vitamins | 1 | 2009 | 1638 | 0.180 |
Why?
|
| Cadmium Poisoning | 4 | 1986 | 11 | 0.180 |
Why?
|
| Manganese | 2 | 2018 | 394 | 0.180 |
Why?
|
| Abdomen | 3 | 2005 | 1136 | 0.170 |
Why?
|
| Transportation | 2 | 2000 | 217 | 0.170 |
Why?
|
| Testicular Diseases | 1 | 2000 | 72 | 0.170 |
Why?
|
| China | 2 | 2024 | 2395 | 0.170 |
Why?
|
| Risk Factors | 29 | 2022 | 74944 | 0.170 |
Why?
|
| Seawater | 1 | 2020 | 126 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 1798 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2012 | 2195 | 0.170 |
Why?
|
| Computer Terminals | 1 | 2000 | 41 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2020 | 2486 | 0.170 |
Why?
|
| Nonprescription Drugs | 1 | 2000 | 119 | 0.170 |
Why?
|
| Diet | 4 | 2005 | 8089 | 0.170 |
Why?
|
| Heart | 2 | 2024 | 4446 | 0.170 |
Why?
|
| Abortion, Spontaneous | 3 | 2000 | 535 | 0.160 |
Why?
|
| Ethiopia | 1 | 2021 | 485 | 0.160 |
Why?
|
| Adolescent | 41 | 2025 | 89169 | 0.160 |
Why?
|
| Environment | 5 | 2016 | 1121 | 0.160 |
Why?
|
| Data Collection | 7 | 2007 | 3327 | 0.160 |
Why?
|
| Quality of Life | 1 | 2021 | 13490 | 0.160 |
Why?
|
| Fetal Growth Retardation | 1 | 2003 | 592 | 0.160 |
Why?
|
| Child Development | 6 | 2008 | 2330 | 0.160 |
Why?
|
| Incineration | 1 | 1998 | 21 | 0.160 |
Why?
|
| Needs Assessment | 3 | 2018 | 1141 | 0.160 |
Why?
|
| Health Care Costs | 3 | 2013 | 3239 | 0.160 |
Why?
|
| Coronary Disease | 3 | 2005 | 5919 | 0.160 |
Why?
|
| Health Care Coalitions | 1 | 2018 | 36 | 0.160 |
Why?
|
| Medical Waste Disposal | 1 | 1998 | 14 | 0.160 |
Why?
|
| Editorial Policies | 1 | 2003 | 458 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2007 | 1135 | 0.150 |
Why?
|
| Premature Birth | 2 | 2023 | 1829 | 0.150 |
Why?
|
| Gold | 1 | 2022 | 488 | 0.150 |
Why?
|
| Waste Management | 1 | 2018 | 19 | 0.150 |
Why?
|
| Universities | 1 | 2024 | 1005 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2015 | 794 | 0.150 |
Why?
|
| Health Education | 3 | 2024 | 1059 | 0.150 |
Why?
|
| Paris | 1 | 2018 | 40 | 0.150 |
Why?
|
| Income | 3 | 2022 | 1878 | 0.150 |
Why?
|
| Manganese Poisoning | 1 | 2018 | 13 | 0.150 |
Why?
|
| Vocational Guidance | 1 | 2017 | 14 | 0.150 |
Why?
|
| Obesity | 4 | 2010 | 13090 | 0.150 |
Why?
|
| Thailand | 1 | 2018 | 288 | 0.150 |
Why?
|
| Cognition Disorders | 4 | 2012 | 3980 | 0.150 |
Why?
|
| Time Factors | 19 | 2024 | 40218 | 0.150 |
Why?
|
| Nausea | 1 | 2000 | 682 | 0.140 |
Why?
|
| Organometallic Compounds | 1 | 2001 | 648 | 0.140 |
Why?
|
| Occupations | 9 | 1993 | 516 | 0.140 |
Why?
|
| Nutritional Sciences | 2 | 2015 | 148 | 0.140 |
Why?
|
| Radioactive Hazard Release | 1 | 2017 | 13 | 0.140 |
Why?
|
| Textile Industry | 1 | 1997 | 74 | 0.140 |
Why?
|
| Measles Vaccine | 10 | 1976 | 79 | 0.140 |
Why?
|
| Life Expectancy | 1 | 2024 | 1248 | 0.140 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2118 | 0.140 |
Why?
|
| Resilience, Psychological | 2 | 2016 | 807 | 0.140 |
Why?
|
| Health Services Accessibility | 4 | 2021 | 5520 | 0.130 |
Why?
|
| Panic Disorder | 2 | 2011 | 613 | 0.130 |
Why?
|
| Edema | 1 | 2000 | 765 | 0.130 |
Why?
|
| Water | 1 | 2023 | 1421 | 0.130 |
Why?
|
| Community-Institutional Relations | 1 | 1998 | 209 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2021 | 828 | 0.130 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2017 | 148 | 0.130 |
Why?
|
| Silicosis | 2 | 1987 | 47 | 0.130 |
Why?
|
| Spectrometry, X-Ray Emission | 3 | 1993 | 144 | 0.130 |
Why?
|
| Combat Disorders | 1 | 1998 | 301 | 0.130 |
Why?
|
| Mass Screening | 6 | 2008 | 5458 | 0.130 |
Why?
|
| Wisconsin | 3 | 2006 | 122 | 0.130 |
Why?
|
| Parkinson Disease | 3 | 2005 | 2893 | 0.130 |
Why?
|
| Paint | 5 | 1996 | 34 | 0.130 |
Why?
|
| Food Safety | 1 | 2016 | 23 | 0.130 |
Why?
|
| Middle Aged | 53 | 2024 | 223492 | 0.130 |
Why?
|
| Lung | 9 | 2018 | 10099 | 0.130 |
Why?
|
| Sewage | 3 | 1988 | 44 | 0.130 |
Why?
|
| Formaldehyde | 3 | 1988 | 362 | 0.130 |
Why?
|
| Urbanization | 2 | 2014 | 100 | 0.130 |
Why?
|
| Brain | 7 | 2021 | 27360 | 0.130 |
Why?
|
| Social Sciences | 1 | 2015 | 40 | 0.130 |
Why?
|
| Models, Educational | 1 | 2018 | 375 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2003 | 1260 | 0.130 |
Why?
|
| Health Personnel | 3 | 2019 | 3385 | 0.120 |
Why?
|
| Rural Health Services | 1 | 2019 | 394 | 0.120 |
Why?
|
| Central Nervous System Diseases | 2 | 2017 | 520 | 0.120 |
Why?
|
| Pan American Health Organization | 1 | 2014 | 5 | 0.120 |
Why?
|
| Civil Defense | 1 | 2017 | 115 | 0.120 |
Why?
|
| DDT | 1 | 1994 | 32 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2018 | 4858 | 0.120 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 360 | 0.120 |
Why?
|
| Measles | 9 | 1976 | 180 | 0.120 |
Why?
|
| Polybrominated Biphenyls | 3 | 2005 | 25 | 0.120 |
Why?
|
| Research Support as Topic | 3 | 2015 | 696 | 0.120 |
Why?
|
| Finland | 1 | 2016 | 609 | 0.120 |
Why?
|
| Porphyrias | 1 | 1994 | 57 | 0.110 |
Why?
|
| Regression Analysis | 5 | 2013 | 6340 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 5 | 1995 | 716 | 0.110 |
Why?
|
| Hemangiosarcoma | 2 | 1993 | 215 | 0.110 |
Why?
|
| Prevalence | 11 | 2011 | 15869 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2012 | 4530 | 0.110 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 1993 | 12 | 0.110 |
Why?
|
| Medicine, Chinese Traditional | 1 | 1994 | 75 | 0.110 |
Why?
|
| Uncertainty | 1 | 2018 | 769 | 0.110 |
Why?
|
| Qualitative Research | 2 | 2022 | 3140 | 0.110 |
Why?
|
| Curriculum | 3 | 2018 | 3782 | 0.110 |
Why?
|
| Creosote | 1 | 1993 | 3 | 0.110 |
Why?
|
| Phosphorus Radioisotopes | 2 | 1990 | 100 | 0.110 |
Why?
|
| Police | 2 | 2013 | 158 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2000 | 1542 | 0.110 |
Why?
|
| Latin America | 1 | 2014 | 416 | 0.110 |
Why?
|
| Goals | 1 | 2018 | 717 | 0.110 |
Why?
|
| Risk | 14 | 2013 | 9613 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 504 | 0.110 |
Why?
|
| Vaccination | 11 | 2013 | 3437 | 0.100 |
Why?
|
| Guidelines as Topic | 3 | 2011 | 1397 | 0.100 |
Why?
|
| Cocarcinogenesis | 1 | 1992 | 49 | 0.100 |
Why?
|
| Socioeconomic Factors | 7 | 2016 | 7852 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 937 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 8128 | 0.100 |
Why?
|
| Students, Medical | 1 | 2006 | 1964 | 0.100 |
Why?
|
| Mexico | 3 | 2010 | 769 | 0.100 |
Why?
|
| Reproduction | 6 | 2000 | 646 | 0.100 |
Why?
|
| Fruit | 1 | 2018 | 1165 | 0.100 |
Why?
|
| Gasoline | 2 | 2022 | 49 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 3929 | 0.100 |
Why?
|
| Vegetables | 1 | 2018 | 1199 | 0.100 |
Why?
|
| Leukemia, Radiation-Induced | 3 | 1987 | 36 | 0.100 |
Why?
|
| Community Networks | 1 | 2014 | 202 | 0.100 |
Why?
|
| Prospective Studies | 13 | 2013 | 54926 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 1997 | 707 | 0.100 |
Why?
|
| Social Security | 1 | 1992 | 101 | 0.100 |
Why?
|
| Phytotherapy | 1 | 1994 | 298 | 0.100 |
Why?
|
| Life Style | 1 | 2003 | 3932 | 0.100 |
Why?
|
| Congresses as Topic | 3 | 2018 | 812 | 0.100 |
Why?
|
| Age Distribution | 1 | 2017 | 2873 | 0.100 |
Why?
|
| Medical History Taking | 3 | 1991 | 779 | 0.100 |
Why?
|
| Human Rights | 2 | 2024 | 312 | 0.100 |
Why?
|
| Health Promotion | 4 | 2003 | 2210 | 0.090 |
Why?
|
| European Union | 2 | 2016 | 158 | 0.090 |
Why?
|
| Brazil | 3 | 2017 | 1250 | 0.090 |
Why?
|
| Mass Casualty Incidents | 1 | 2013 | 180 | 0.090 |
Why?
|
| Rats | 5 | 2021 | 23760 | 0.090 |
Why?
|
| Physicians | 2 | 2006 | 4598 | 0.090 |
Why?
|
| Respiration Disorders | 2 | 1986 | 364 | 0.090 |
Why?
|
| Resins, Synthetic | 1 | 2010 | 25 | 0.090 |
Why?
|
| Pleural Diseases | 1 | 1991 | 138 | 0.090 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2010 | 45 | 0.090 |
Why?
|
| Pit and Fissure Sealants | 1 | 2010 | 27 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 1997 | 939 | 0.090 |
Why?
|
| Disasters | 1 | 2017 | 521 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 663 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7454 | 0.090 |
Why?
|
| Societies, Medical | 3 | 2019 | 3968 | 0.090 |
Why?
|
| Wounds and Injuries | 3 | 1997 | 2517 | 0.090 |
Why?
|
| Hospitalization | 2 | 2021 | 10840 | 0.090 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 424 | 0.080 |
Why?
|
| Safety | 3 | 2004 | 1159 | 0.080 |
Why?
|
| Workers' Compensation | 4 | 1993 | 150 | 0.080 |
Why?
|
| Communication | 1 | 2024 | 3905 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1514 | 0.080 |
Why?
|
| Parents | 2 | 2018 | 3595 | 0.080 |
Why?
|
| Privatization | 1 | 2009 | 41 | 0.080 |
Why?
|
| Weather | 1 | 2010 | 234 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 414 | 0.080 |
Why?
|
| Mental Health | 3 | 2011 | 3275 | 0.080 |
Why?
|
| Cause of Death | 4 | 1992 | 3721 | 0.080 |
Why?
|
| Joint Diseases | 3 | 1991 | 461 | 0.080 |
Why?
|
| Cost Control | 1 | 2011 | 627 | 0.080 |
Why?
|
| Arsenic Poisoning | 4 | 1983 | 55 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 5536 | 0.080 |
Why?
|
| Aged | 30 | 2017 | 171504 | 0.080 |
Why?
|
| Beverages | 1 | 1994 | 819 | 0.080 |
Why?
|
| beta 2-Microglobulin | 2 | 2007 | 330 | 0.080 |
Why?
|
| Chlordecone | 3 | 1990 | 3 | 0.080 |
Why?
|
| Anemia | 4 | 1991 | 1514 | 0.080 |
Why?
|
| Rivers | 1 | 2008 | 65 | 0.080 |
Why?
|
| Developed Countries | 2 | 2016 | 451 | 0.080 |
Why?
|
| Trichloroethylene | 1 | 1987 | 13 | 0.080 |
Why?
|
| Creatinine | 4 | 2003 | 1918 | 0.070 |
Why?
|
| Pneumococcal Infections | 1 | 2013 | 529 | 0.070 |
Why?
|
| Acne Vulgaris | 1 | 1993 | 352 | 0.070 |
Why?
|
| Allied Health Personnel | 1 | 2009 | 156 | 0.070 |
Why?
|
| Heart Rate | 2 | 1997 | 4214 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2000 | 3445 | 0.070 |
Why?
|
| Pneumoconiosis | 4 | 1992 | 32 | 0.070 |
Why?
|
| Acetylglucosaminidase | 2 | 1998 | 66 | 0.070 |
Why?
|
| Women's Health | 3 | 2008 | 2082 | 0.070 |
Why?
|
| Muscular Diseases | 2 | 1991 | 553 | 0.070 |
Why?
|
| Science | 1 | 2010 | 236 | 0.070 |
Why?
|
| Smoking | 10 | 2011 | 9092 | 0.070 |
Why?
|
| Bone Diseases | 1 | 1991 | 416 | 0.070 |
Why?
|
| Kidney | 4 | 1998 | 7064 | 0.070 |
Why?
|
| Cadmium | 5 | 2015 | 217 | 0.070 |
Why?
|
| Neural Conduction | 5 | 1988 | 443 | 0.070 |
Why?
|
| Radium | 1 | 2007 | 70 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1862 | 0.070 |
Why?
|
| Age Factors | 13 | 2021 | 18412 | 0.070 |
Why?
|
| Erythrocytes | 3 | 1994 | 2418 | 0.070 |
Why?
|
| Health Status Indicators | 2 | 2010 | 969 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 2973 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2020 | 5107 | 0.070 |
Why?
|
| Masks | 1 | 1989 | 214 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1560 | 0.070 |
Why?
|
| Cotinine | 2 | 2021 | 206 | 0.070 |
Why?
|
| Vibration | 3 | 1995 | 335 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 1741 | 0.070 |
Why?
|
| Depression | 4 | 2012 | 8230 | 0.070 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2005 | 22 | 0.070 |
Why?
|
| Placenta | 1 | 2015 | 1725 | 0.060 |
Why?
|
| DNA | 2 | 1990 | 7214 | 0.060 |
Why?
|
| Radon | 1 | 2007 | 91 | 0.060 |
Why?
|
| Smoke | 3 | 2024 | 242 | 0.060 |
Why?
|
| Hot Temperature | 2 | 2010 | 1441 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2005 | 62 | 0.060 |
Why?
|
| Football | 1 | 1991 | 506 | 0.060 |
Why?
|
| Prejudice | 1 | 2010 | 574 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2021 | 3857 | 0.060 |
Why?
|
| Idaho | 6 | 1992 | 17 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 781 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9374 | 0.060 |
Why?
|
| Clinical Protocols | 1 | 1991 | 1443 | 0.060 |
Why?
|
| Mediterranean Sea | 1 | 2024 | 13 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2007 | 386 | 0.060 |
Why?
|
| Sudan | 1 | 2005 | 86 | 0.060 |
Why?
|
| Leukocytes | 3 | 1990 | 2035 | 0.060 |
Why?
|
| History, 18th Century | 3 | 1995 | 206 | 0.060 |
Why?
|
| Environmental Medicine | 2 | 2001 | 15 | 0.060 |
Why?
|
| Body Weights and Measures | 1 | 2005 | 208 | 0.060 |
Why?
|
| Porphyrins | 1 | 1987 | 352 | 0.060 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2741 | 0.060 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2024 | 86 | 0.060 |
Why?
|
| Styrene | 3 | 1993 | 23 | 0.060 |
Why?
|
| Ethylene Oxide | 1 | 1984 | 28 | 0.060 |
Why?
|
| Seychelles | 1 | 2003 | 5 | 0.060 |
Why?
|
| Crops, Agricultural | 1 | 2024 | 37 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 1996 | 1907 | 0.060 |
Why?
|
| Asia | 2 | 2018 | 629 | 0.060 |
Why?
|
| Glass | 2 | 1985 | 116 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 836 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8759 | 0.060 |
Why?
|
| Insect Control | 1 | 2003 | 28 | 0.060 |
Why?
|
| Paraquat | 1 | 1983 | 36 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2013 | 1188 | 0.050 |
Why?
|
| Nuclear Reactors | 1 | 1983 | 8 | 0.050 |
Why?
|
| Gonads | 1 | 2003 | 109 | 0.050 |
Why?
|
| Propane | 1 | 1983 | 12 | 0.050 |
Why?
|
| Genetic Markers | 1 | 1990 | 2603 | 0.050 |
Why?
|
| Educational Status | 1 | 2011 | 2515 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3139 | 0.050 |
Why?
|
| Pentachlorophenol | 1 | 2003 | 10 | 0.050 |
Why?
|
| Rubella | 2 | 1974 | 55 | 0.050 |
Why?
|
| Recreation | 1 | 2003 | 124 | 0.050 |
Why?
|
| Schools | 1 | 1991 | 1498 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1793 | 0.050 |
Why?
|
| Polyvinyl Chloride | 1 | 1982 | 32 | 0.050 |
Why?
|
| India | 2 | 2013 | 2334 | 0.050 |
Why?
|
| Cumulative Trauma Disorders | 2 | 1997 | 152 | 0.050 |
Why?
|
| Virginia | 2 | 2001 | 115 | 0.050 |
Why?
|
| Diarrhea | 1 | 2009 | 1320 | 0.050 |
Why?
|
| Health Care Sector | 1 | 2024 | 196 | 0.050 |
Why?
|
| Ferritins | 1 | 2005 | 601 | 0.050 |
Why?
|
| Hydrogen Sulfide | 1 | 1983 | 147 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2022 | 105 | 0.050 |
Why?
|
| Respiratory Insufficiency | 2 | 2011 | 1240 | 0.050 |
Why?
|
| Stilbenes | 1 | 1983 | 155 | 0.050 |
Why?
|
| Arsenicals | 1 | 1982 | 117 | 0.050 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1983 | 98 | 0.050 |
Why?
|
| Sinusitis | 1 | 2011 | 997 | 0.050 |
Why?
|
| Health Occupations | 1 | 1984 | 225 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 1982 | 455 | 0.050 |
Why?
|
| Psychophysiologic Disorders | 1 | 1983 | 223 | 0.050 |
Why?
|
| Noise | 1 | 2024 | 295 | 0.050 |
Why?
|
| Government Agencies | 2 | 2004 | 161 | 0.050 |
Why?
|
| Preventive Health Services | 1 | 2006 | 570 | 0.050 |
Why?
|
| Disabled Persons | 3 | 2016 | 1210 | 0.050 |
Why?
|
| Pennsylvania | 2 | 2017 | 615 | 0.050 |
Why?
|
| Polyvinyls | 1 | 1982 | 154 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2013 | 1541 | 0.050 |
Why?
|
| Testicular Neoplasms | 2 | 2003 | 806 | 0.050 |
Why?
|
| Albuminuria | 1 | 2005 | 658 | 0.050 |
Why?
|
| Minority Groups | 2 | 1999 | 1216 | 0.050 |
Why?
|
| Benzoates | 1 | 2003 | 213 | 0.050 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2004 | 468 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2014 | 2389 | 0.050 |
Why?
|
| Denmark | 1 | 2003 | 776 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2278 | 0.050 |
Why?
|
| Japan | 1 | 2005 | 1418 | 0.050 |
Why?
|
| Vitamin E | 1 | 2005 | 874 | 0.050 |
Why?
|
| Oxides | 1 | 1982 | 403 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2018 | 8741 | 0.040 |
Why?
|
| Nose Neoplasms | 1 | 1983 | 250 | 0.040 |
Why?
|
| Urban Health | 2 | 2003 | 535 | 0.040 |
Why?
|
| Health | 1 | 2003 | 398 | 0.040 |
Why?
|
| Interinstitutional Relations | 1 | 2001 | 235 | 0.040 |
Why?
|
| Social Control, Formal | 1 | 2001 | 107 | 0.040 |
Why?
|
| Puberty | 1 | 2003 | 501 | 0.040 |
Why?
|
| Consumer Product Safety | 2 | 2016 | 122 | 0.040 |
Why?
|
| Hair | 6 | 2010 | 508 | 0.040 |
Why?
|
| Cluster Analysis | 3 | 2009 | 2732 | 0.040 |
Why?
|
| Cross-Sectional Studies | 8 | 2013 | 26379 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12252 | 0.040 |
Why?
|
| Death Certificates | 2 | 1992 | 172 | 0.040 |
Why?
|
| Erectile Dysfunction | 1 | 1983 | 437 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3803 | 0.040 |
Why?
|
| Radiography | 6 | 1994 | 6983 | 0.040 |
Why?
|
| Mice | 4 | 2021 | 82029 | 0.040 |
Why?
|
| Endocrine Glands | 1 | 1999 | 101 | 0.040 |
Why?
|
| Cyclopentanes | 1 | 1979 | 87 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2006 | 2434 | 0.040 |
Why?
|
| Uruguay | 1 | 2018 | 104 | 0.040 |
Why?
|
| Health Transition | 1 | 1998 | 35 | 0.040 |
Why?
|
| Hypertension | 4 | 1991 | 8616 | 0.040 |
Why?
|
| Triglycerides | 2 | 2005 | 2464 | 0.040 |
Why?
|
| Demography | 3 | 2003 | 1641 | 0.040 |
Why?
|
| Fluorescence | 2 | 1994 | 756 | 0.040 |
Why?
|
| Semen | 1 | 2000 | 349 | 0.040 |
Why?
|
| Disclosure | 1 | 2003 | 755 | 0.040 |
Why?
|
| Respiratory System | 1 | 2021 | 564 | 0.040 |
Why?
|
| Rubella Vaccine | 3 | 1974 | 23 | 0.040 |
Why?
|
| Young Adult | 5 | 2017 | 60066 | 0.040 |
Why?
|
| Bhopal Accidental Release | 1 | 2017 | 1 | 0.040 |
Why?
|
| Seveso Accidental Release | 1 | 2017 | 2 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11928 | 0.040 |
Why?
|
| DEET | 1 | 1997 | 11 | 0.040 |
Why?
|
| Chemical Warfare | 1 | 1997 | 18 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 1997 | 32 | 0.040 |
Why?
|
| Biphenyl Compounds | 2 | 1979 | 1026 | 0.040 |
Why?
|
| Plants | 1 | 1979 | 332 | 0.040 |
Why?
|
| Insect Repellents | 1 | 1997 | 18 | 0.040 |
Why?
|
| Iron | 1 | 1986 | 1813 | 0.040 |
Why?
|
| Hematologic Diseases | 2 | 1991 | 498 | 0.030 |
Why?
|
| Ghana | 1 | 2018 | 333 | 0.030 |
Why?
|
| Cannabis | 1 | 1983 | 446 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2018 | 10760 | 0.030 |
Why?
|
| Animal Diseases | 1 | 1976 | 12 | 0.030 |
Why?
|
| Israel | 2 | 2013 | 726 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 1998 | 227 | 0.030 |
Why?
|
| Porphobilinogen Synthase | 1 | 1996 | 29 | 0.030 |
Why?
|
| Travel | 1 | 2022 | 805 | 0.030 |
Why?
|
| Cholesterol | 1 | 2005 | 2914 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2008 | 3205 | 0.030 |
Why?
|
| Comorbidity | 1 | 2011 | 10590 | 0.030 |
Why?
|
| Organizational Affiliation | 1 | 1995 | 34 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 4938 | 0.030 |
Why?
|
| Dichlorodiphenyldichloroethane | 1 | 2015 | 6 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2011 | 13053 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5367 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14783 | 0.030 |
Why?
|
| Neuromuscular Diseases | 3 | 1989 | 260 | 0.030 |
Why?
|
| Veterans | 3 | 1998 | 2669 | 0.030 |
Why?
|
| Child Advocacy | 1 | 1995 | 48 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 20227 | 0.030 |
Why?
|
| Training Support | 1 | 1995 | 109 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1997 | 241 | 0.030 |
Why?
|
| Ventilation | 1 | 1975 | 129 | 0.030 |
Why?
|
| North America | 1 | 1998 | 1289 | 0.030 |
Why?
|
| Liability, Legal | 1 | 2016 | 209 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 1997 | 406 | 0.030 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 1994 | 85 | 0.030 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 1990 | 176 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1994 | 80 | 0.030 |
Why?
|
| Bivalvia | 1 | 1994 | 55 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2012 | 6874 | 0.030 |
Why?
|
| Sex Factors | 7 | 1992 | 10632 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 944 | 0.030 |
Why?
|
| Powders | 1 | 1994 | 79 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1992 | 1485 | 0.030 |
Why?
|
| Health Surveys | 3 | 2012 | 4057 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 1995 | 377 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 1997 | 1001 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1999 | 1338 | 0.030 |
Why?
|
| Measles virus | 2 | 1973 | 67 | 0.030 |
Why?
|
| Physical Examination | 1 | 2000 | 1263 | 0.030 |
Why?
|
| Industrial Oils | 1 | 1993 | 13 | 0.030 |
Why?
|
| Immunoglobulins | 3 | 1974 | 855 | 0.030 |
Why?
|
| Budgets | 1 | 1995 | 232 | 0.030 |
Why?
|
| Models, Organizational | 1 | 1997 | 548 | 0.030 |
Why?
|
| Kidney Function Tests | 3 | 1986 | 684 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1994 | 167 | 0.030 |
Why?
|
| Weapons | 1 | 2013 | 17 | 0.030 |
Why?
|
| Philippines | 1 | 2013 | 95 | 0.030 |
Why?
|
| Sentinel Surveillance | 1 | 1995 | 292 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2005 | 3329 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2000 | 6412 | 0.030 |
Why?
|
| Touch | 1 | 1995 | 316 | 0.030 |
Why?
|
| Preconception Care | 1 | 1994 | 143 | 0.030 |
Why?
|
| Indians, North American | 1 | 1997 | 354 | 0.030 |
Why?
|
| Indonesia | 1 | 2013 | 131 | 0.030 |
Why?
|
| Perceptual Disorders | 1 | 1975 | 199 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 4249 | 0.030 |
Why?
|
| Forecasting | 3 | 1990 | 2945 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2024 | 1985 | 0.030 |
Why?
|
| Calcium | 1 | 1986 | 5792 | 0.030 |
Why?
|
| South Africa | 1 | 1998 | 1873 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 1997 | 365 | 0.030 |
Why?
|
| Life Tables | 1 | 1992 | 367 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 1973 | 79 | 0.030 |
Why?
|
| Antibody Formation | 3 | 1974 | 1393 | 0.030 |
Why?
|
| Hepatitis A | 1 | 1973 | 126 | 0.020 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2015 | 249 | 0.020 |
Why?
|
| Wood | 2 | 1985 | 94 | 0.020 |
Why?
|
| Vitamin D | 1 | 1986 | 3311 | 0.020 |
Why?
|
| Exercise Test | 1 | 2000 | 2186 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2000 | 4030 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 1994 | 435 | 0.020 |
Why?
|
| Uric Acid | 1 | 1998 | 805 | 0.020 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 395 | 0.020 |
Why?
|
| Pakistan | 1 | 2013 | 299 | 0.020 |
Why?
|
| Motor Skills | 1 | 1975 | 523 | 0.020 |
Why?
|
| Child Mortality | 1 | 2014 | 204 | 0.020 |
Why?
|
| Risk Management | 1 | 1995 | 558 | 0.020 |
Why?
|
| Decision Making | 2 | 2021 | 3953 | 0.020 |
Why?
|
| Poverty Areas | 2 | 2009 | 268 | 0.020 |
Why?
|
| Women's Rights | 1 | 1992 | 66 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1984 | 2496 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23645 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5196 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 3986 | 0.020 |
Why?
|
| Immunity | 2 | 1974 | 1003 | 0.020 |
Why?
|
| Birth Certificates | 1 | 2011 | 71 | 0.020 |
Why?
|
| Self Mutilation | 1 | 1971 | 57 | 0.020 |
Why?
|
| Chelation Therapy | 1 | 1991 | 77 | 0.020 |
Why?
|
| New Hampshire | 2 | 1987 | 174 | 0.020 |
Why?
|
| Ataxia | 1 | 1973 | 307 | 0.020 |
Why?
|
| Purpura | 1 | 1971 | 117 | 0.020 |
Why?
|
| Carps | 1 | 2010 | 51 | 0.020 |
Why?
|
| Quebec | 1 | 2010 | 139 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22291 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 1991 | 289 | 0.020 |
Why?
|
| Drainage, Sanitary | 1 | 2009 | 1 | 0.020 |
Why?
|
| Bolivia | 1 | 2009 | 22 | 0.020 |
Why?
|
| Acute Disease | 3 | 1992 | 7243 | 0.020 |
Why?
|
| Fisheries | 1 | 2010 | 48 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 39348 | 0.020 |
Why?
|
| Rural Health | 1 | 1990 | 302 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1973 | 463 | 0.020 |
Why?
|
| Chromosome Aberrations | 2 | 1987 | 1778 | 0.020 |
Why?
|
| School Health Services | 1 | 1972 | 388 | 0.020 |
Why?
|
| Europe | 1 | 1995 | 3436 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2021 | 3080 | 0.020 |
Why?
|
| Hippurates | 1 | 1988 | 15 | 0.020 |
Why?
|
| Functional Laterality | 1 | 1995 | 2264 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 1990 | 394 | 0.020 |
Why?
|
| Toluene | 1 | 1988 | 34 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1992 | 573 | 0.020 |
Why?
|
| Cholinesterases | 2 | 1979 | 32 | 0.020 |
Why?
|
| Rural Population | 1 | 2019 | 2325 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2012 | 9669 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.020 |
Why?
|
| Low Back Pain | 1 | 1997 | 990 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 1085 | 0.020 |
Why?
|
| Dimethylformamide | 1 | 1987 | 20 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2000 | 4541 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 2 | 1986 | 189 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1987 | 66 | 0.020 |
Why?
|
| Tendinopathy | 1 | 1991 | 174 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1997 | 2025 | 0.020 |
Why?
|
| Radiation, Ionizing | 2 | 1986 | 252 | 0.020 |
Why?
|
| Arm | 1 | 1991 | 591 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3728 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 1994 | 2633 | 0.020 |
Why?
|
| Rubber | 1 | 1987 | 31 | 0.020 |
Why?
|
| Jurisprudence | 1 | 1987 | 109 | 0.020 |
Why?
|
| Retrospective Studies | 10 | 2012 | 81762 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 1984 | 4282 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 4 | 1974 | 87 | 0.020 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1991 | 304 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1983 | 4058 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 297 | 0.020 |
Why?
|
| Back Pain | 1 | 1991 | 548 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 21206 | 0.020 |
Why?
|
| Respiratory Function Tests | 2 | 2010 | 1695 | 0.020 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1986 | 56 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2015 | 1628 | 0.020 |
Why?
|
| Kentucky | 2 | 1979 | 83 | 0.020 |
Why?
|
| Neutron Activation Analysis | 1 | 1986 | 35 | 0.020 |
Why?
|
| Ohio | 1 | 1987 | 321 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 550 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1983 | 4423 | 0.020 |
Why?
|
| Polyurethanes | 1 | 1986 | 110 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2744 | 0.020 |
Why?
|
| Nuclear Energy | 2 | 1986 | 15 | 0.020 |
Why?
|
| Medical Records | 1 | 1991 | 1410 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1990 | 2000 | 0.020 |
Why?
|
| Vaccines | 1 | 1974 | 842 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3436 | 0.020 |
Why?
|
| Resins, Plant | 1 | 1985 | 20 | 0.020 |
Why?
|
| Electronics | 1 | 1986 | 317 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 354 | 0.020 |
Why?
|
| Azo Compounds | 1 | 1985 | 116 | 0.010 |
Why?
|
| X-Rays | 1 | 1986 | 311 | 0.010 |
Why?
|
| Self Report | 1 | 2016 | 3773 | 0.010 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2004 | 25 | 0.010 |
Why?
|
| Phosphorus | 1 | 1986 | 336 | 0.010 |
Why?
|
| Mutagens | 2 | 1986 | 181 | 0.010 |
Why?
|
| Skin Absorption | 1 | 1985 | 96 | 0.010 |
Why?
|
| Diphtheria Toxoid | 2 | 1974 | 25 | 0.010 |
Why?
|
| Teratoma | 1 | 1987 | 405 | 0.010 |
Why?
|
| California | 1 | 1989 | 1438 | 0.010 |
Why?
|
| Pertussis Vaccine | 2 | 1974 | 39 | 0.010 |
Why?
|
| Fetus | 1 | 1992 | 1883 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1991 | 1375 | 0.010 |
Why?
|
| Sister Chromatid Exchange | 1 | 1984 | 60 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1991 | 1384 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1989 | 870 | 0.010 |
Why?
|
| Tetanus Toxoid | 2 | 1974 | 188 | 0.010 |
Why?
|
| Pacific Islands | 1 | 2003 | 52 | 0.010 |
Why?
|
| Local Government | 1 | 2004 | 83 | 0.010 |
Why?
|
| Pharmacology | 1 | 2003 | 97 | 0.010 |
Why?
|
| Lymphoma | 1 | 1993 | 1898 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2003 | 115 | 0.010 |
Why?
|
| Cockroaches | 1 | 2003 | 92 | 0.010 |
Why?
|
| Headache | 2 | 1983 | 1263 | 0.010 |
Why?
|
| Spirometry | 1 | 2006 | 929 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1994 | 5902 | 0.010 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 1988 | 542 | 0.010 |
Why?
|
| Health Services Research | 1 | 1991 | 1815 | 0.010 |
Why?
|
| Haplorhini | 1 | 1984 | 523 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1990 | 841 | 0.010 |
Why?
|
| Cities | 1 | 2005 | 543 | 0.010 |
Why?
|
| Social Support | 1 | 2013 | 2193 | 0.010 |
Why?
|
| Dog Diseases | 2 | 1990 | 143 | 0.010 |
Why?
|
| Publication Bias | 1 | 2003 | 158 | 0.010 |
Why?
|
| Syndrome | 2 | 1983 | 3272 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2008 | 724 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1983 | 240 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 1982 | 76 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12543 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1991 | 13014 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1998 | 8543 | 0.010 |
Why?
|
| Data Display | 1 | 1983 | 174 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1992 | 2846 | 0.010 |
Why?
|
| Paresthesia | 2 | 1974 | 160 | 0.010 |
Why?
|
| Seasons | 3 | 1973 | 1524 | 0.010 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1982 | 65 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1983 | 239 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14729 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 59629 | 0.010 |
Why?
|
| Models, Biological | 1 | 1998 | 9495 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3833 | 0.010 |
Why?
|
| Weight Loss | 1 | 1993 | 2721 | 0.010 |
Why?
|
| Submarine Medicine | 1 | 1981 | 4 | 0.010 |
Why?
|
| Water Pollution, Chemical | 2 | 1978 | 30 | 0.010 |
Why?
|
| Geography | 1 | 2003 | 652 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1984 | 337 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1983 | 310 | 0.010 |
Why?
|
| Hematopoietic System | 1 | 1981 | 110 | 0.010 |
Why?
|
| Energy Intake | 1 | 2008 | 2146 | 0.010 |
Why?
|
| Chromosomes | 1 | 1984 | 578 | 0.010 |
Why?
|
| Dizziness | 1 | 1983 | 269 | 0.010 |
Why?
|
| Hobbies | 1 | 1980 | 5 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2003 | 344 | 0.010 |
Why?
|
| Tibia | 1 | 1986 | 1076 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1982 | 312 | 0.010 |
Why?
|
| Iowa | 2 | 1997 | 100 | 0.010 |
Why?
|
| Vermont | 1 | 1979 | 80 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1984 | 632 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12077 | 0.010 |
Why?
|
| Monocrotophos | 1 | 1979 | 2 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1983 | 638 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 65371 | 0.010 |
Why?
|
| Multiple Chemical Sensitivity | 1 | 1998 | 7 | 0.010 |
Why?
|
| Pain | 3 | 1983 | 5100 | 0.010 |
Why?
|
| Mitogens | 1 | 1979 | 229 | 0.010 |
Why?
|
| Eggs | 1 | 1980 | 182 | 0.010 |
Why?
|
| Absorption | 2 | 1978 | 244 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1992 | 4045 | 0.010 |
Why?
|
| Dogs | 2 | 1990 | 3845 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14164 | 0.010 |
Why?
|
| Edetic Acid | 2 | 1990 | 278 | 0.010 |
Why?
|
| Social Environment | 1 | 2003 | 1012 | 0.010 |
Why?
|
| Michigan | 1 | 1979 | 330 | 0.010 |
Why?
|
| Copper | 2 | 1979 | 368 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1979 | 1609 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 1979 | 5505 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15948 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13290 | 0.010 |
Why?
|
| Pharyngeal Diseases | 1 | 1979 | 134 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1979 | 412 | 0.010 |
Why?
|
| Parathion | 1 | 1977 | 14 | 0.010 |
Why?
|
| Lipids | 1 | 1989 | 3343 | 0.010 |
Why?
|
| Flour | 1 | 1977 | 22 | 0.010 |
Why?
|
| Urban Population | 2 | 2003 | 2046 | 0.010 |
Why?
|
| Software | 1 | 1991 | 4478 | 0.010 |
Why?
|
| Rabbits | 1 | 1984 | 4772 | 0.010 |
Why?
|
| Education, Medical | 1 | 1989 | 1742 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2907 | 0.010 |
Why?
|
| Antibodies, Viral | 5 | 1976 | 3216 | 0.010 |
Why?
|
| Posture | 2 | 1992 | 957 | 0.010 |
Why?
|
| Analgesics | 1 | 1984 | 1071 | 0.010 |
Why?
|
| Cricetinae | 1 | 1981 | 2423 | 0.010 |
Why?
|
| Tennessee | 1 | 1977 | 123 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1990 | 2599 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1982 | 936 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1983 | 2357 | 0.010 |
Why?
|
| Glioma | 1 | 1991 | 3503 | 0.010 |
Why?
|
| Skin Neoplasms | 2 | 1990 | 5863 | 0.010 |
Why?
|
| Cat Diseases | 1 | 1976 | 32 | 0.010 |
Why?
|
| Clothing | 1 | 1977 | 96 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1992 | 8080 | 0.010 |
Why?
|
| Cattle Diseases | 1 | 1976 | 50 | 0.010 |
Why?
|
| Alabama | 1 | 1976 | 112 | 0.010 |
Why?
|
| Proteinuria | 1 | 1979 | 611 | 0.010 |
Why?
|
| Horse Diseases | 1 | 1976 | 55 | 0.010 |
Why?
|
| Neurologic Manifestations | 1 | 1975 | 19 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1981 | 1230 | 0.010 |
Why?
|
| Horses | 1 | 1976 | 295 | 0.010 |
Why?
|
| Cooking and Eating Utensils | 1 | 1975 | 3 | 0.010 |
Why?
|
| Vaccines, Attenuated | 2 | 1976 | 314 | 0.010 |
Why?
|
| Colic | 1 | 1975 | 43 | 0.010 |
Why?
|
| Skin | 1 | 1989 | 4503 | 0.010 |
Why?
|
| Hematocrit | 1 | 1976 | 623 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1988 | 7140 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 7598 | 0.010 |
Why?
|
| Pica | 1 | 1975 | 37 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 1975 | 88 | 0.010 |
Why?
|
| Cats | 1 | 1976 | 978 | 0.010 |
Why?
|
| Farmer's Lung | 1 | 1974 | 2 | 0.010 |
Why?
|
| Prognosis | 1 | 1995 | 30010 | 0.010 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1974 | 24 | 0.010 |
Why?
|
| El Salvador | 1 | 1974 | 34 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1975 | 256 | 0.010 |
Why?
|
| Air | 1 | 1975 | 187 | 0.010 |
Why?
|
| Students | 1 | 1983 | 1744 | 0.010 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 1973 | 26 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1979 | 660 | 0.010 |
Why?
|
| Minnesota | 1 | 1974 | 339 | 0.010 |
Why?
|
| Milk | 1 | 1976 | 438 | 0.010 |
Why?
|
| Commerce | 1 | 1979 | 612 | 0.010 |
Why?
|
| Zinc | 1 | 1977 | 677 | 0.010 |
Why?
|
| Micronesia | 1 | 1973 | 44 | 0.010 |
Why?
|
| Illinois | 1 | 1973 | 120 | 0.010 |
Why?
|
| Carnivora | 1 | 1972 | 28 | 0.010 |
Why?
|
| Sports Medicine | 1 | 1975 | 239 | 0.010 |
Why?
|
| Byssinosis | 1 | 1992 | 36 | 0.010 |
Why?
|
| Rubella virus | 1 | 1972 | 11 | 0.010 |
Why?
|
| Aging | 1 | 1992 | 8744 | 0.010 |
Why?
|
| Reflex, Abnormal | 1 | 1973 | 83 | 0.010 |
Why?
|
| Arkansas | 1 | 1972 | 59 | 0.010 |
Why?
|
| Meningoencephalitis | 1 | 1973 | 82 | 0.010 |
Why?
|
| Rabies | 1 | 1972 | 56 | 0.010 |
Why?
|
| Encephalitis | 2 | 1973 | 441 | 0.010 |
Why?
|
| Learning | 1 | 1982 | 1759 | 0.010 |
Why?
|
| Urinary Bladder Diseases | 1 | 1973 | 166 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1975 | 418 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1973 | 104 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1975 | 914 | 0.010 |
Why?
|
| Zoonoses | 1 | 1972 | 180 | 0.010 |
Why?
|
| Noise, Occupational | 1 | 1991 | 26 | 0.010 |
Why?
|
| Meningitis | 1 | 1973 | 219 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1974 | 738 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1974 | 381 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1973 | 560 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1979 | 2614 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1975 | 506 | 0.010 |
Why?
|
| Klebsiella pneumoniae | 1 | 1973 | 253 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1992 | 272 | 0.010 |
Why?
|
| Cattle | 1 | 1976 | 3819 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1991 | 320 | 0.010 |
Why?
|
| Calibration | 1 | 1993 | 819 | 0.010 |
Why?
|
| Liver | 1 | 1986 | 7577 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1978 | 957 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1976 | 1531 | 0.010 |
Why?
|
| Mutation | 3 | 1986 | 30238 | 0.010 |
Why?
|
| Biophysics | 1 | 1991 | 379 | 0.010 |
Why?
|
| Biopsy | 4 | 1975 | 6793 | 0.010 |
Why?
|
| Immunization | 1 | 1974 | 1219 | 0.010 |
Why?
|
| Laboratories | 1 | 1993 | 463 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1973 | 490 | 0.000 |
Why?
|
| Massachusetts | 1 | 1982 | 8890 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1974 | 535 | 0.000 |
Why?
|
| Family | 1 | 1980 | 3209 | 0.000 |
Why?
|
| Deafness | 1 | 1973 | 460 | 0.000 |
Why?
|
| Antigens | 1 | 1974 | 1442 | 0.000 |
Why?
|
| Acetaminophen | 1 | 1972 | 552 | 0.000 |
Why?
|
| Accreditation | 1 | 1991 | 476 | 0.000 |
Why?
|
| Mandible | 1 | 1973 | 754 | 0.000 |
Why?
|
| Muscles | 1 | 1973 | 1582 | 0.000 |
Why?
|
| Certification | 1 | 1991 | 420 | 0.000 |
Why?
|
| Leg | 1 | 1973 | 1088 | 0.000 |
Why?
|
| Maine | 1 | 1988 | 146 | 0.000 |
Why?
|
| Peroneal Nerve | 1 | 1988 | 80 | 0.000 |
Why?
|
| Gait | 1 | 1973 | 823 | 0.000 |
Why?
|
| Welding | 1 | 1988 | 89 | 0.000 |
Why?
|
| Mutagenicity Tests | 1 | 1986 | 46 | 0.000 |
Why?
|
| Fertility | 1 | 1992 | 771 | 0.000 |
Why?
|
| Viral Vaccines | 1 | 1972 | 596 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1973 | 724 | 0.000 |
Why?
|
| Naval Medicine | 1 | 1986 | 30 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1973 | 2089 | 0.000 |
Why?
|
| Radiation Dosage | 2 | 1988 | 1967 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1979 | 4793 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1986 | 311 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1975 | 2474 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 370 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1534 | 0.000 |
Why?
|
| Connecticut | 2 | 1978 | 366 | 0.000 |
Why?
|
| Immunoglobulin M | 3 | 1975 | 1528 | 0.000 |
Why?
|
| Fever | 1 | 1972 | 1614 | 0.000 |
Why?
|
| Protective Devices | 1 | 1985 | 72 | 0.000 |
Why?
|
| Antibodies | 1 | 1973 | 2421 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1973 | 1397 | 0.000 |
Why?
|
| Physician's Role | 1 | 1991 | 925 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1984 | 18349 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1986 | 876 | 0.000 |
Why?
|
| Poisoning | 2 | 1978 | 252 | 0.000 |
Why?
|
| Cognition | 1 | 1982 | 7073 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1973 | 1554 | 0.000 |
Why?
|
| Alaska | 1 | 1983 | 68 | 0.000 |
Why?
|
| Leukemia, Myeloid | 1 | 1986 | 693 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1973 | 2714 | 0.000 |
Why?
|
| Genotype | 1 | 1977 | 13045 | 0.000 |
Why?
|
| Probability | 1 | 1988 | 2479 | 0.000 |
Why?
|
| Seizures | 1 | 1975 | 2998 | 0.000 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1973 | 1930 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1979 | 10266 | 0.000 |
Why?
|
| Nicaragua | 1 | 1981 | 29 | 0.000 |
Why?
|
| Aroclors | 1 | 1980 | 3 | 0.000 |
Why?
|
| Immunoglobulin A | 2 | 1975 | 992 | 0.000 |
Why?
|
| Aspirin | 1 | 1972 | 3135 | 0.000 |
Why?
|
| Explosions | 1 | 1981 | 106 | 0.000 |
Why?
|
| Indiana | 1 | 1980 | 93 | 0.000 |
Why?
|
| Animal Feed | 1 | 1980 | 105 | 0.000 |
Why?
|
| Agriculture | 1 | 1980 | 186 | 0.000 |
Why?
|
| Arizona | 1 | 1979 | 108 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1981 | 1627 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1980 | 526 | 0.000 |
Why?
|
| Chickens | 1 | 1980 | 845 | 0.000 |
Why?
|
| Immunoglobulin G | 3 | 1975 | 4568 | 0.000 |
Why?
|
| Dibucaine | 1 | 1977 | 7 | 0.000 |
Why?
|
| Butyrylcholinesterase | 1 | 1977 | 21 | 0.000 |
Why?
|
| Colorado | 1 | 1978 | 167 | 0.000 |
Why?
|
| Jamaica | 1 | 1977 | 54 | 0.000 |
Why?
|
| Bayes Theorem | 1 | 1985 | 2359 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1975 | 94 | 0.000 |
Why?
|
| Photomicrography | 1 | 1974 | 71 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1974 | 141 | 0.000 |
Why?
|
| Antibodies, Fungal | 1 | 1974 | 33 | 0.000 |
Why?
|
| Antigens, Fungal | 1 | 1974 | 69 | 0.000 |
Why?
|
| Guatemala | 1 | 1974 | 161 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1974 | 556 | 0.000 |
Why?
|
| Nigeria | 1 | 1976 | 781 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1974 | 687 | 0.000 |
Why?
|
| Homozygote | 1 | 1977 | 1779 | 0.000 |
Why?
|
| Louisiana | 1 | 1972 | 104 | 0.000 |
Why?
|
| Immune Sera | 1 | 1972 | 605 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1975 | 668 | 0.000 |
Why?
|
| Pulmonary Alveoli | 1 | 1975 | 665 | 0.000 |
Why?
|
| Hypoxia, Brain | 1 | 1972 | 139 | 0.000 |
Why?
|
| North Carolina | 1 | 1972 | 329 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1979 | 1206 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1981 | 1437 | 0.000 |
Why?
|
| Heterozygote | 1 | 1977 | 2798 | 0.000 |
Why?
|
| Pedigree | 1 | 1977 | 4539 | 0.000 |
Why?
|
| Body Temperature | 1 | 1972 | 780 | 0.000 |
Why?
|
| Eosinophils | 1 | 1974 | 952 | 0.000 |
Why?
|
| Autopsy | 1 | 1972 | 1011 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1972 | 1760 | 0.000 |
Why?
|
| Clinical Trials as Topic | 2 | 1974 | 8054 | 0.000 |
Why?
|
| Dyspnea | 1 | 1975 | 1352 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1974 | 1162 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1972 | 4755 | 0.000 |
Why?
|